Factors | Disease-free (n = 84) | Progresseda (n = 21) | P | ||
---|---|---|---|---|---|
n | % | n | % | ||
Tissue visfatin | <Â 0.001 | ||||
 ≤ 50% | 51 | 60.7 | 4 | 19.0 |  |
 > 50% | 33 | 39.3 | 17 | 81.0 |  |
Stage | <Â 0.001 | ||||
 I, II | 73 | 86.9 | 10 | 47.6 |  |
 III, IV | 11 | 13.1 | 11 | 52.4 |  |
Grade | 0.669 | ||||
 1, 2 | 60 | 71.4 | 14 | 66.7 |  |
 3 | 24 | 28.6 | 7 | 33.3 |  |
Age (years) | 0.002 | ||||
 < 50 | 51 | 60.7 | 5 | 23.8 |  |
 ≥ 50 | 33 | 39.3 | 16 | 76.2 |  |
BMI (kg/m2) | 0.195 | ||||
 < 24 | 53 | 63.1 | 10 | 47.6 |  |
 ≥ 24 | 31 | 36.9 | 11 | 52.4 |  |
Tumor size (cm) | 0.007 | ||||
 < 2 | 44 | 52.4 | 4 | 19.0 |  |
 ≥ 2 | 40 | 47.6 | 17 | 81.0 |  |
LN metastasis | <Â 0.001 | ||||
 Negative | 59 | 70.2 | 6 | 28.6 |  |
 Positive | 25 | 29.8 | 15 | 71.4 |  |
ER | 0.051 | ||||
 Positive | 59 | 70.2 | 10 | 47.6 |  |
 Negative | 25 | 29.8 | 11 | 52.4 |  |
PR | 0.139 | ||||
 Positive | 51 | 60.7 | 9 | 42.9 |  |
 Negative | 33 | 39.3 | 12 | 57.1 |  |
HER2 status | 0.417 | ||||
 Positive | 32 | 38.1 | 6 | 28.6 |  |
 Negative | 52 | 61.9 | 15 | 71.4 |  |
Triple negative | 0.031 | ||||
 No | 70 | 83.3 | 13 | 61.9 |  |
 Yes | 14 | 16.7 | 8 | 38.1 |  |
RT | 0.487 | ||||
 Yes | 51 | 60.7 | 11 | 52.4 |  |
 No | 33 | 39.3 | 10 | 47.6 |  |
CT | 0.557 | ||||
 Yes | 66 | 78.6 | 18 | 85.7 |  |
 No | 18 | 21.4 | 3 | 14.3 |  |
HT | <Â 0.001 | ||||
 Yes | 60 | 71.4 | 6 | 28.6 |  |
 No | 24 | 28.6 | 15 | 71.4 |  |